156 related articles for article (PubMed ID: 37507241)
1. Does Urologist-level Utilization of Active Surveillance for Low-risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses?
Wang M; Wittenberg S; Cher ML; Van Til M; Ferrante S; Mirza M; Johnson A; Semerjian A; George A; Rogers C; Wilder S; Sarle R; Ghani KR; Lane B; Ginsburg KB;
Eur Urol; 2024 Feb; 85(2):101-104. PubMed ID: 37507241
[TBL] [Abstract][Full Text] [Related]
2. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
Womble PR; Montie JE; Ye Z; Linsell SM; Lane BR; Miller DC;
Eur Urol; 2015 Jan; 67(1):44-50. PubMed ID: 25159890
[TBL] [Abstract][Full Text] [Related]
3. The increasing use of renal tumor biopsy amongst Canadian urologists: When is biopsy most utilized?
Couture F; Finelli T; Breau RH; Mallick R; Bhindi B; Tanguay S; Kapoor A; Rendon RA; Pouliot F; Lavallée L; Fairey AS; So A; Richard PO
Urol Oncol; 2021 Aug; 39(8):499.e15-499.e22. PubMed ID: 34187749
[TBL] [Abstract][Full Text] [Related]
4. Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.
Finelli A; Cheung DC; Al-Matar A; Evans AJ; Morash CG; Pautler SE; Siemens DR; Tanguay S; Rendon RA; Gleave ME; Drachenberg DE; Chin JL; Fleshner NE; Haider MA; Kachura JR; Sykes J; Jewett MAS
Eur Urol; 2020 Sep; 78(3):460-467. PubMed ID: 32680677
[TBL] [Abstract][Full Text] [Related]
5. Update on active surveillance for clinical T1 renal tumors.
Joice GA; Pierorazio PM; Allaf ME
Curr Opin Urol; 2016 Sep; 26(5):405-9. PubMed ID: 27262141
[TBL] [Abstract][Full Text] [Related]
6. Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer.
Radhakrishnan A; Wallner LP; Skolarus TA; George AK; Rosenberg BH; Abrahamse P; Hawley ST
J Urol; 2022 Sep; 208(3):600-608. PubMed ID: 35522191
[TBL] [Abstract][Full Text] [Related]
7. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
[TBL] [Abstract][Full Text] [Related]
8. Contemporary management of small renal masses: does practice environment matter?
Smith PH; Elliott VL; Raman JD
Can J Urol; 2012 Oct; 19(5):6438-42. PubMed ID: 23040625
[TBL] [Abstract][Full Text] [Related]
9. Current status of renal biopsy for small renal masses.
Ha SB; Kwak C
Korean J Urol; 2014 Sep; 55(9):568-73. PubMed ID: 25237457
[TBL] [Abstract][Full Text] [Related]
10. The role of active surveillance of small renal masses.
Volpe A
Int J Surg; 2016 Dec; 36(Pt C):518-524. PubMed ID: 27321381
[TBL] [Abstract][Full Text] [Related]
11. The Impact of a Statewide Active Surveillance Initiative: A Roadmap for Increasing Active Surveillance Utilization Nationwide.
Vince RA; Sun Y; Mahal B; Ginsburg K; George A; Cher M; Lane B; Sarle R; Morgan TM; Spratt DE
Eur Urol; 2023 Apr; 83(4):307-310. PubMed ID: 35688664
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound (CEUS) imaging for active surveillance of small renal masses.
Bertelli E; Palombella A; Sessa F; Baldi I; Morelli N; Verna S; Greco I; Morselli S; Pili A; Sebastianelli A; Berni A; Nicoletti R; Minervini A; Carini M; Gacci M; Miele V; Agostini S; Serni S; Campi R
World J Urol; 2021 Aug; 39(8):2853-2860. PubMed ID: 33495864
[TBL] [Abstract][Full Text] [Related]
13. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
14. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.
Ellis SD; Hwang S; Morrow E; Kimminau KS; Goonan K; Petty L; Ellerbeck E; Thrasher JB
BMC Cancer; 2021 May; 21(1):649. PubMed ID: 34058998
[TBL] [Abstract][Full Text] [Related]
15. Patients' perceptions on active surveillance for the treatment of small renal masses.
Charbonneau G; Hudon C; Lavallée LT; Kassouf W; Gaboury I; Toren P; Couture F; Couture F; Foley V; Tétu A; Richard PO
Urol Oncol; 2022 Nov; 40(11):493.e17-493.e23. PubMed ID: 35961846
[TBL] [Abstract][Full Text] [Related]
16. Conditional survival of patients with small renal masses undergoing active surveillance.
Petros FG; Venkatesan AM; Kaya D; Ng CS; Fellman BM; Karam JA; Wood CG; Matin SF
BJU Int; 2019 Mar; 123(3):447-455. PubMed ID: 30007044
[TBL] [Abstract][Full Text] [Related]
17. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
Pierorazio PM; Johnson MH; Ball MW; Gorin MA; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME
Eur Urol; 2015 Sep; 68(3):408-15. PubMed ID: 25698065
[TBL] [Abstract][Full Text] [Related]
18. A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer.
Kato T; Tohi Y; Honda T; Matsuda I; Osaki Y; Naito H; Matsuoka Y; Okazoe H; Taoka R; Tsunemori H; Ueda N; Sugimoto M
Int J Urol; 2023 Mar; 30(3):289-297. PubMed ID: 36415128
[TBL] [Abstract][Full Text] [Related]
19. Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer.
Radhakrishnan A; Subramanian L; Rankin AJ; Fetters MD; Wittmann DA; Ginsburg KB; Hawley ST; Skolarus TA
Ann Fam Med; 2024; 22(1):5-11. PubMed ID: 38253492
[TBL] [Abstract][Full Text] [Related]
20. Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance.
Rasmussen RG; Xi Y; Sibley RC; Lee CJ; Cadeddu JA; Pedrosa I
AJR Am J Roentgenol; 2022 Jan; 218(1):101-110. PubMed ID: 34286596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
